Search research articles
Contact Us
Filters
Showing results (1161-1170 of 1,187) with videos related to
Page
of 119
Sort By:
Annals of Internal Medicine
|
May 22, 2023
Temporal Trends in the Use of Computed Tomographic Pulmonary Angiography for Suspected Pulmonary Embolism in the Emergency Department : A Retrospective Analysis
Melanie Roussel, Ben Bloom, Mehdi Taalba, et al.
British Journal of Anaesthesia
|
April 22, 2020
Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations
Wenlong Yao, Tingting Wang, Bailin Jiang, et al.
Cancer Medicine
|
May 22, 2020
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment
Lucia Nogova, Christian Mattonet, Matthias Scheffler, et al.
Cell
|
May 1, 2026
An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut
Luisella Spiga, Ryan T Fansler, Yifan Wu, et al.
Plos Genetics
|
June 5, 2020
In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
Olga Kim, Eun Young Park, David L Klinkebiel, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
An Anaerobic Pathogen Rewires Host Metabolism to Fuel Oxidative Growth in the Inflamed Gut
Luisella Spiga, Ryan T Fansler, Alexandra Grote, et al.
Cancer Cell
|
June 14, 2022
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma
Vidhya M Ravi, Paulina Will, Jan Kueckelhaus, et al.
Lancet (London, England)
|
December 26, 2014
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Karolin Behringer, Helen Goergen, Felicitas Hitz, et al.
Trials
|
November 4, 2021
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML
Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Nature Communications
|
September 11, 2021
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer
Vrutant V Shah, Aundrietta D Duncan, Shiming Jiang, et al.
Page
of 119
Search research articles
Search
Showing results (1161-1170 of 1,187) with videos related to
Sort By:
Page
of 119
Annals of Internal Medicine
|
May 22, 2023
Temporal Trends in the Use of Computed Tomographic Pulmonary Angiography for Suspected Pulmonary Embolism in the Emergency Department : A Retrospective Analysis
Melanie Roussel, Ben Bloom, Mehdi Taalba, et al.
British Journal of Anaesthesia
|
April 22, 2020
Emergency tracheal intubation in 202 patients with COVID-19 in Wuhan, China: lessons learnt and international expert recommendations
Wenlong Yao, Tingting Wang, Bailin Jiang, et al.
Cancer Medicine
|
May 22, 2020
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment
Lucia Nogova, Christian Mattonet, Matthias Scheffler, et al.
Cell
|
May 1, 2026
An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut
Luisella Spiga, Ryan T Fansler, Yifan Wu, et al.
Plos Genetics
|
June 5, 2020
In vivo modeling of metastatic human high-grade serous ovarian cancer in mice
Olga Kim, Eun Young Park, David L Klinkebiel, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2025
An Anaerobic Pathogen Rewires Host Metabolism to Fuel Oxidative Growth in the Inflamed Gut
Luisella Spiga, Ryan T Fansler, Alexandra Grote, et al.
Cancer Cell
|
June 14, 2022
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma
Vidhya M Ravi, Paulina Will, Jan Kueckelhaus, et al.
Lancet (London, England)
|
December 26, 2014
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial
Karolin Behringer, Helen Goergen, Felicitas Hitz, et al.
Trials
|
November 4, 2021
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML
Sonia Jaramillo, Johannes Krisam, Lucian Le Cornet, et al.
Nature Communications
|
September 11, 2021
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer
Vrutant V Shah, Aundrietta D Duncan, Shiming Jiang, et al.
Page
of 119